登录 | 注册    关注公众号  
微信公众号
搜索
 > 【HLA-A*02:01 & B2M & NY-ESO-1】

HLA-A*02:01 & B2M & NY-ESO-1产品列表

ACRO质量管理体系
 
评论(3)
HL1-H52E7|Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein (MALS verified)
  1. 151XXXXXXX5
  2. 4人赞
  3. 选择acro产品实验数据比较放心,产品使用说明,给出的参数,方便实验人员,选择acro一般不会出错,是我们实验室的优选品牌,还会回购
  4. 2022-12-09
HL1-H52E7|Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein (MALS verified)
  1. 181XXXXXXX6
  2. 0人赞
  3. 我们购买这款蛋白是用于筛选抗体的,做ELISA用这款蛋白灵敏度高,蛋白活性很好,得到了很好的数据,一直在Acro购买蛋白,Acro值得信赖。
  4. 2023-10-24
HL1-H82E4|Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Complex Protein (Monomer, MALS verified)
  1. 176XXXXXXX6
  2. 0人赞
  3. 实验效果很好,与预期结果一致,效果得到众多领导的一致好评,以后还会继续订购贵公司的产品,希望与贵公司继续保持良好合作
  4. 2023-07-18
 

HLA-A*02:01 & B2M & NY-ESO-1分子别名

HLA-A*02:01 & B2M & NY-ESO-1

HLA-A*02:01 & B2M & NY-ESO-1分子背景

NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A2 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients.

消息提示

请输入您的联系方式,再点击提交!

确定